Connection

Yazdan Yazdanpanah to Hepatitis B

Back to Details
This is a "connection" page, showing publications Yazdan Yazdanpanah has written about Hepatitis B.
Yazdan Yazdanpanah
Connection Strength
0.216
Hepatitis B
  1. The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice. Eur J Gen Pract. 2018 Dec; 24(1):60-67.
    View in: PubMed
    Score: 0.096
  2. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017 12; 46(11-12):1054-1060.
    View in: PubMed
    Score: 0.096
  3. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 11; 4(11):e486-e494.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.